Jazz Pharmaceuticals Non-GAAP EPS of -$8.25 misses by $2.00, revenue of $1.05B in-line
Source: SeekingAlpha
2025-08-05 16:14:42 ET
More on Jazz Pharmaceuticals
- Jazz Pharmaceuticals: I See Big Potential In This Stock As An Investor
- Jazz Pharmaceuticals: One Step Forward, One Back
- Jazz Pharmaceuticals Q2 2025 Earnings Preview
- Jazz Pharmaceuticals names Renee Gala as CEO
- Seeking Alpha’s Quant Rating on Jazz Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Jazz Pharmaceuticals Non-GAAP EPS of -$8.25 misses by $2.00, revenue of $1.05B in-line
iHuman Inc. American depositary shares each representing five Class A
NASDAQ: IH
IH Trading
-0.51% G/L:
$1.95 Last:
1,897 Volume:
$2.03 Open:
IH Latest News
September 18, 2025 04:30:00 am
iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results
